Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F A Shepherd

Showing results (81-90 of 175) with videos related to

Pageof 18
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1987
Acute leukemia during pregnancy: the Toronto Leukemia Study Group experience with long-term follow-up of children exposed in utero to chemotherapeutic agentsE E Reynoso, F A Shepherd, H A Messner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1985
Carcinoembryonic antigen: a useful prognostic marker in small-cell lung cancerJ P Sculier, R Feld, W K Evans, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 1, 1988
Combination chemotherapy and alpha-interferon in the treatment of Kaposi's sarcoma associated with acquired immune deficiency syndromeF A Shepherd, W K Evans, B Garvey, et al.
Cancer|August 16, 2001
Phase II study of pemetrexed disodium, a multitargeted antifolate, and cisplatin as first-line therapy in patients with advanced nonsmall cell lung carcinoma: a study of the National Cancer Institute of Canada Clinical Trials GroupF A Shepherd, J Dancey, A Arnold, et al.
Seminars in Oncology|June 1, 1997
Phase II trial of gemcitabine and weekly cisplatin for advanced non-small cell lung cancerF A Shepherd, Y Cormier, R Burkes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1983
Intramedullary spinal cord metastases from small cell carcinoma of the lungK C Murphy, R Feld, W K Evans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1993
Importance of clinical staging in limited small-cell lung cancer: a valuable system to separate prognostic subgroups. The University of Toronto Lung Oncology GroupF A Shepherd, R J Ginsberg, R Haddad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1992
Phase I-II study of high-dose epirubicin in advanced non-small-cell lung cancerR Feld, R Wierzbicki, P L Walde, et al.
Seminars in Oncology|April 1, 1990
A phase II study of ifosfamide, cisplatin, etoposide in patients with advanced non-small cell lung cancer: a preliminary reportF A Shepherd, P E Goss, J Latreille, et al.
British Journal of Cancer|April 28, 2006
Amplification of telomerase (hTERT) gene is a poor prognostic marker in non-small-cell lung cancerC-Q Zhu, J-C Cutz, N Liu, et al.
Pageof 18

Showing results (81-90 of 175) with videos related to

Sort By:
Pageof 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1987
Acute leukemia during pregnancy: the Toronto Leukemia Study Group experience with long-term follow-up of children exposed in utero to chemotherapeutic agentsE E Reynoso, F A Shepherd, H A Messner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1985
Carcinoembryonic antigen: a useful prognostic marker in small-cell lung cancerJ P Sculier, R Feld, W K Evans, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 1, 1988
Combination chemotherapy and alpha-interferon in the treatment of Kaposi's sarcoma associated with acquired immune deficiency syndromeF A Shepherd, W K Evans, B Garvey, et al.
Cancer|August 16, 2001
Phase II study of pemetrexed disodium, a multitargeted antifolate, and cisplatin as first-line therapy in patients with advanced nonsmall cell lung carcinoma: a study of the National Cancer Institute of Canada Clinical Trials GroupF A Shepherd, J Dancey, A Arnold, et al.
Seminars in Oncology|June 1, 1997
Phase II trial of gemcitabine and weekly cisplatin for advanced non-small cell lung cancerF A Shepherd, Y Cormier, R Burkes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1983
Intramedullary spinal cord metastases from small cell carcinoma of the lungK C Murphy, R Feld, W K Evans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1993
Importance of clinical staging in limited small-cell lung cancer: a valuable system to separate prognostic subgroups. The University of Toronto Lung Oncology GroupF A Shepherd, R J Ginsberg, R Haddad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1992
Phase I-II study of high-dose epirubicin in advanced non-small-cell lung cancerR Feld, R Wierzbicki, P L Walde, et al.
Seminars in Oncology|April 1, 1990
A phase II study of ifosfamide, cisplatin, etoposide in patients with advanced non-small cell lung cancer: a preliminary reportF A Shepherd, P E Goss, J Latreille, et al.
British Journal of Cancer|April 28, 2006
Amplification of telomerase (hTERT) gene is a poor prognostic marker in non-small-cell lung cancerC-Q Zhu, J-C Cutz, N Liu, et al.
Pageof 18